Discover the Evidence, Ethics, and Emerging Practices in Psychedelic-Assisted Therapy (PAT)
Join leading experts in psychiatry and mental health for an in-depth exploration of the rapidly evolving field of psychedelic-assisted therapy. This webinar will offer a comprehensive look at the clinical, ethical, and therapeutic aspects of psychedelic medicine and its place in modern psychiatric practice.
The renewed clinical interest in psychedelics brings both promise and controversy. Are the benefits being overstated? What are the potential risks? How does PAT differ from conventional therapy? This evidence-based discussion will cover:
- Clinical use of MDMA, psilocybin and ketamine
- PAT training and regulation in Australia
- Ethical and legal considerations
- The risks versus benefits in clinical applications
- Psychotherapy integration and limitations
Who Should Attend?
Psychiatrists, psychologists, psychotherapists, general practitioners, nurses, mental health clinicians, and trainees in related fields.
